Study on the effects and active component of Smilax glabra in treating migraine
Planta Medica · 19.11.2026
DOI: 10.1055/a-3007-0883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 19.11.2026. Verfasst von Nuo Chen und 5 weiteren Autor:innen. Gefördert von: Foundation of Old Chinese Medicine Inheritance Studio of Li Hanmin in Hubei Province, the Open Fund of Hubei Key Laboratory of Resources and Chemistry of Chinese Medicine, Research Project for Practice Development of National TCM Clinical Research Bases.
Abstract (Originalsprache)
Background:In recent years, the incidence of migraine has increased year by year, and it is still the second largest cause of disability in the world. Migraine accounts for 5.6% of the global disease burden, exceeding the sum of all other nervous system diseases, because its onset often begins at the age of 25-34 and reaches its peak at the age of 35-39, which seriously affects people's work ability and causes a serious burden to society and families. However, at present, the clinical efficacy of various drugs are not ideal, and there are adverse reactions. Therefore, it is urgent to research and develop drugs with good safety and definite curative effect.
Purpose
A large number of clinical studies showed that Smilax glabra had a good effect on treating migraine. However, there is no content of Smilax glabra on treating migraine in Chinese medicine books, and there is no research report on Smilax glabra on treating migraine and related active ingredients in modern research. Therefore, we intend to adopt modern analysis and pharmacological methods to clarify the therapeutic effects of Smilax glabra on migraine and related active components.
Methods
The active components of Rhizoma Smilacis Glabrae in preventing and treating migraine were studied by network pharmacological analysis and brain tissue chemical detection. The analgesic effect of Smilax glabra, astilbin and astilbin vesicles on writhing induced by acetic acid and pain threshold of heat stimulated mice was studied. To study the effects of Smilax glabra, astilbin and astilbin vesicles on migraine model animals.
Förderung
- Foundation of Old Chinese Medicine Inheritance Studio of Li Hanmin in Hubei Province
- the Open Fund of Hubei Key Laboratory of Resources and Chemistry of Chinese Medicine
- Research Project for Practice Development of National TCM Clinical Research Bases
Zitieren
APA
Chen, N., Liu, Y., Yu, S., Yan, J., Chang, M., & Li, H. (2026). Study on the effects and active component of Smilax glabra in treating migraine. Planta Medica. https://doi.org/10.1055/a-3007-0883
Vancouver
Chen N, Liu Y, Yu S, Yan J, Chang M, Li H. Study on the effects and active component of Smilax glabra in treating migraine. Planta Medica. 2026. doi:10.1055/a-3007-0883
BibTeX
@article{Chen2026,
author = {Chen, Nuo and Liu, Yanqing and Yu, Siwen and Yan, Jingsong and Chang, Mingxiang and Li, Hanmin},
title = {Study on the effects and active component of Smilax glabra in treating migraine},
journal = {Planta Medica},
year = {2026},
doi = {10.1055/a-3007-0883}
}
EUVIMED